Life Sciences Tools and Services
Company Overview of Data Sciences International, Inc.
Data Sciences International, Inc. operates as a biomedical research company that focuses on systems physiology and pharmacology. The company offers telemetry devices, instrumentation, and software and services for physiological monitoring. Its portfolio includes wireless physiologic monitoring solutions, such as implantable telemetry transmitters that sense, process, and transmit information via telemetry from within an animal of any size; and Bluetooth-enabled external telemetry devices that collect ECG, blood pressure, respiration, temperature, and activity in freely moving/unstressed animals. The company also provides software platforms for the acquisition and analysis of physiological da...
119 14th Street NW
St. Paul, MN 55112
Founded in 1984
Key Executives for Data Sciences International, Inc.
Chief Scientific Officer and Vice President
Compensation as of Fiscal Year 2015.
Data Sciences International, Inc. Key Developments
Data Sciences International, Inc. Launches Telemetry Implant for Continuous Real-Time Glucose Measurement
May 21 14
Data Sciences International (DSI) has introduced the first-ever glucose telemetry implant for obtaining continuous, real-time measurements of blood glucose in laboratory animals. Because the sensor is placed directly into the bloodstream, researchers are now able to detect instantaneous changes in blood glucose, body temperature, and activity for 28 days or longer while reducing animal stress and measurement variability commonly associated with the use of glucose test strips. The Centers for Disease Control and Prevention (CDC) estimates that diabetes affects 26 million people in the U.S. alone, or 8.3% of the population. Diabetes is a major cause of heart disease, stroke, kidney failure, lower-limb amputations, and blindness. The National Institutes of Health (NIH) is providing an estimated $1 billion in funding for diabetes research in 2014. In addition, with nearly every major pharmaceutical company engaged in the development of new treatments for diabetes and metabolic disease, demand for better research instrumentation has also increased.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries